Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Eli Lilly & Co. (NY: LLY)
55.02 USD  -0.88 (-1.57%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Eli Lilly & Co.
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients
Today 8:00 EDT
Video shows how those from the medical field bring patient care experience to pharmaceutical career Read More
from PR Newswire
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
May 18, 2013
Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the stock price will move higher and they... Read More
category GHDX , Benzinga , Murphy Oil , and 35 more.
from Latest Articles from Benzinga.com
Opportunity in Cyclical Stocks
May 17, 2013
 Read More
category NYSE:COP , NYSE:XOM , NYSE:CVX , and 2 more.
from InvestorPlace - Latest Headlines
Cheerleaders: Look Beyond Pharma For Jobs
May 16, 2013
category AZN , ABBV , TSPT , and 5 more.
from YCharts
Notable ETF Inflow Detected - VHT, JNJ, LLY, UNH
May 16, 2013
Symbols mentioned in this story: VHT, JNJ, LLY, UNH Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
GE Healthcare Targets Growth Markets And New Technologies To Drive Sales
May 16, 2013
category Pharmaceuticals , Industrials
from Trefis
Lilly Oncology to Release New Pipeline Data at ASCO 2013
May 14, 2013
Data from Pipeline Molecules Targeting Key Cancer Pathways to be Presented Read More
from PR Newswire
PreMarket Info Recap for May 14, 2013
May 14, 2013
Have you ever woken up to find that a stock in your portfolio made a dramatic move overnight? Are you interested in learning how to understand each day's post-market and pre-market moves? Veteran... Read More
category TTWO , Benzinga , Movers , and 9 more.
from Latest Articles from Benzinga.com
Lilly Provides Update on CEO Dr. John Lechleiter
May 14, 2013
from PR Newswire
Perfect Trade Setups, How to Play NLY, CHK, WCRX and LLY
May 14, 2013
from Marketwired News Releases
Stocks Crossing 50-Day SMA 05/13: (ZNGA) (FB) (LLY) Above; (T) (AFFY) (BTU) Below
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8331885 for the full story. Read More
from StreetInsider.com News Articles
Dyax prices $30M direct offering to develop HAE candidate
May 13, 2013
category Health Care , Gustav Christensen , Technology , and 5 more.
from Business Journals
Options Update for Eli Lilly &
May 13, 2013
NEW YORK (AVAFIN) -- Options traders were heavily trading call contracts during the last ... Read More
from AVAFIN
The Straight Truth, Investing in C, LLY, AMZN and FB
May 11, 2013
from Marketwired News Releases
Eli Lilly (LLY) flat as product falls short
May 10, 2013
Eli Lilly and Company (NYSE: LLY) nicked higher 0.1% to $54.56 after the company announced its Enzastaurin Phase III Study had failed to meet Primary Endpoint in Diffuse Large B-Cell Lymphoma. Share... Read More
from BAYSTREET RSS FEED
“Marketing Without Innovation”: a Merck Story
May 10, 2013
category AZN , MRK , GSK , and 3 more.
from YCharts
Eli Lilly to Take Q2 Charge on Enzastaurin Trial News; Maintains Outlook (LLY)
May 10, 2013
Pharmaceutical company, Eli Lilly & Co. (LLY) reported that it will stop the development of Enzastaurin, which will result in a second quarter R&D charge. The company has been developing a drug called... Read More
category lly , Dividend Stocks , Eli Lilly & Co/
from Dividend Daily
Strategy Behind Our Success, We Get in Early: LLY, COP, GE and EXC
May 10, 2013
from Marketwired News Releases
Benzinga's Top Pre-Market Losers
May 10, 2013
Pain Therapeutics Inc. (NASDAQ: PTIE ) dipped 45.01% to $5.32 in the pre-market session after the company CEO revealed a letter from Pfizer (NYSE: PFE ) of reassessing its endorsement of the Remoxy... Read More
category SNTS , Benzinga , Benzinga's Top Pre/Market Losers , and 9 more.
from Latest Articles from Benzinga.com
Eli Lilly's lymphoma drug fails in late-stage trial
May 10, 2013
May 10 (Reuters) - Eli Lilly and Co said it will stop developing its experimental cancer drug after a late-stage trial failed to show a statistically significant increase in patients' disease-free... Read More
category companyNews
from Reuters: Company News
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
May 10, 2013
Eli Lilly and Company (NYSE: LLY ) announced today Phase III clinical trial results from enzastaurin's PRELUDE study, which explored the molecule as a monotherapy in the prevention of relapse in... Read More
category Benzinga , News , FDA , and 1 more.
from Latest Articles from Benzinga.com
Lilly (LLY) to Halt Enzastaurin Production Following Phase III; Sees Charge
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8325772 for the full story. Read More
from StreetInsider.com News Articles
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
May 10, 2013
from PR Newswire
Pharma’s Failure: Drug Spending Finally Declines
May 09, 2013
category AZN , MRK , GSK , and 3 more.
from YCharts
10 Big Name Stocks Going Ex-Dividend Next Week (May 13-17)
May 09, 2013
Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its upcoming dividend payout. For more information, check... Read More
category lly , cost , tgt , and 9 more.
from Dividend Daily
Big Drug Companies Are Selling Fewer Pills, But Charging More
May 09, 2013
One thing that you may not realize about big drug companies is that, in terms of the number of pills they sell, they are much less big than they were just five years ago. As many popular drugs have... Read More
category NASDAQ:TEVA , NYSE:NVS , NYSE:MRK , and 2 more.
from Forbes Real Time
U.S. spending on medicines fell for first time in 2012
May 08, 2013
May 9 (Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years,... Read More
category companyNews
from Reuters: Company News
For Farmers, Rise in Suicide Rate Is Old News
May 08, 2013
What didn't make the papers last week is that for American farmers in economic distress, suicide has always been the leading killer. Read More
category DOW , SFD , TSN , and 1 more.
from Minyanville Headlines
The Next Billionaire: A Statistician Who Changed Medicine
May 08, 2013
Over the next few days, Dennis Gillings, a statistician who helped create the multibillion-dollar industry of conducting research studies for drug giants, is likely to enter an exclusive club: those... Read More
category NYSE:CVD , NYSE:AGN , NYSE:Q , and 1 more.
from Forbes Real Time
The Reason It Trades, What's Moving LLY, MBI, REGN and BMY
May 08, 2013
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
6 Healthy Products That Aren't
Diane Bullock
2
Random Thoughts: A Signal That Bears Watching
Todd Harrison
3
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
4
The Video Game Industry Is Facing a Mobile Zombie Apocalypse
André Mouton
5
This Bull Has Further to Run, but Markets Look Vulnerable in July or August
Jeff Saut

Financial Product Guide